Tessera Therapeutics
Chunxi (Chauncey) Zeng is an accomplished scientist with extensive experience in mRNA design and gene technology. Currently serving as Associate Director at Tessera Therapeutics, Chunxi focuses on developing novel mRNAs for Gene Writing™ technology. Previous roles include Research Scientist at The Ohio State University Wexner Medical Center and Postdoc/Research Associate at Ohio State University, where Chunxi's work centered on optimizing mRNA expression and resulted in a pending US patent for optimized mRNA sequences. Additional experience includes teaching Organic Chemistry as an Adjunct Lecturer at Ohio University and substantial teaching and supervisory roles within the Department of Chemistry & Biochemistry at Ohio University. Chunxi began a career in quality control at Chengdu Institute of Biological Products and contributed to disaster relief efforts in child protection after the Sichuan earthquake. Chunxi holds a Ph.D. in Biochemistry, Molecular & Cellular Biology from Ohio University and a Bachelor of Science in Biotechnology from Sichuan University.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.